Preview: Quoin Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Quoin Pharmaceuticals (NASDAQ:QNRX) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-2.31. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price following past earnings reports, with the last quarter's beat leading to an 8.26% drop in share price. Currently, shares are trading at $1.14, marking an 81.67% decline over the last 52 weeks.
March 12, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Quoin Pharmaceuticals is expected to report an EPS of $-2.31 for the upcoming quarter. Historical performance shows significant stock price volatility post-earnings announcements.
Given the historical volatility in Quoin Pharmaceuticals' stock price following earnings reports, the upcoming announcement could lead to similar short-term fluctuations. However, the direction of the impact (positive or negative) is uncertain, hence a neutral score. The importance is high due to the potential for significant price movement, but confidence is not at maximum due to the unpredictable nature of market reactions to earnings reports.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100